Pedro Del Campo-Duran

Majadahonda, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Roxadustat in lupus nephritis: a novel therapeutic signal for multifactorial anaemia.

Roxadustat in lupus nephritis: a novel therapeutic signal for multifactorial anaemia.

Journal: Lupus science & medicine

Published: May 06, 2026

Impact of systemic autoimmune diseases in maternal, fetal and neonatal outcomes in Spain.

Impact of systemic autoimmune diseases in maternal, fetal and neonatal outcomes in Spain.

Journal: Rheumatology (Oxford, England)

Published: February 01, 2026

Impact of comorbidities and organ damage on hospital admissions and mortality in patients with sarcoidosis: an observational study from the Spanish National Registry.

Impact of comorbidities and organ damage on hospital admissions and mortality in patients with sarcoidosis: an observational study from the Spanish National Registry.

Journal: Internal and emergency medicine

Published: July 29, 2025

Higher Mortality Risk From Ovarian Carcinomas, Small Bowel Neoplasms, and B-Cell and Mucosa-Associated Lymphoid Tissue Lymphomas in Sjögren Syndrome Patients.

Higher Mortality Risk From Ovarian Carcinomas, Small Bowel Neoplasms, and B-Cell and Mucosa-Associated Lymphoid Tissue Lymphomas in Sjögren Syndrome Patients.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: January 17, 2025

Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study.

Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study.

Journal: BMC rheumatology

Published: November 27, 2024

IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients.

IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients.

Journal: Viruses

Published: April 29, 2024

Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry.

Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the Spanish National Registry.

Journal: Lupus science & medicine

Published: January 21, 2024

Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry.

Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry.

Journal: Journal of translational autoimmunity

Published: December 13, 2023

Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study.

Systemic Autoimmune Diseases in Patients Hospitalized with COVID-19 in Spain: A Nation-Wide Registry Study.

Journal: Viruses

Published: June 11, 2022

Impact of severe infections in SLE: an observational study from the Spanish national registry.

Impact of severe infections in SLE: an observational study from the Spanish national registry.

Journal: Lupus science & medicine

Published: April 04, 2022

Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus.

Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus.

Journal: Journal of translational autoimmunity

Published: February 14, 2022

Serum cytokines to predict systemic lupus erythematosus clinical and serological activity.

Serum cytokines to predict systemic lupus erythematosus clinical and serological activity.

Journal: Clinical and translational science

Published: February 13, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026